|
|
Prepublished online as a Blood First Edition Paper on January 30, 2003; DOI 10.1182/blood-2002-11-3569.
 Previous Article | Table of Contents | Next Article 
Blood, 1 June 2003, Vol. 101, No. 11, pp. 4500-4504
IMMUNOBIOLOGY
A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells
Nadia L. Bernasconi,
Nobuyuki Onai, and
Antonio Lanzavecchia
From the Institute for Research in Biomedicine, Bellinzona, Switzerland.
 |
Abstract
|
|---|
Toll-like receptors (TLRs) are pattern recognition receptors that trigger innate immunity. In this study we investigated the expression of 10 TLRs in human naive and memory B-cell subsets. We report that in human naive B cells most TLRs are expressed at low to undetectable levels, but the expression of TLR9 and TLR10 is rapidly induced following B-cell-receptor (BCR) triggering. In contrast, memory B cells express several TLRs at constitutively high levels. The differential expression of TLR9 correlates with responsiveness to its agonist, CpG DNA. Thus, human memory B cells proliferate and differentiate to immunoglobulin (Ig)–secreting cells in response to CpG, while naive B do so only if simultaneously triggered through the BCR. The BCR-induced expression of TLRs in human naive B cells prevents polyclonal activation in a primary response, because it restricts stimulation to antigen-specific B cells. In contrast, the constitutive expression of TLRs in memory B cells allows polyclonal activation of the entire memory pool. Thus, in human B cells TLRs are downstream of BCR and play a role both in the primary response and in the memory phase.
|
Introduction
|
|---|
Toll-like receptors (TLRs) are pattern recognition receptors that trigger innate immunity, providing both immediate protective responses against pathogens and instructing the adaptive immune response through the induction of dendritic cell recruitment and maturation.1, 2, 3, 4 TLR triggering results in nuclear factor kappa B (NF- B)–mediated activation of inflammatory genes.5 Ten TLRs have been described in humans, and agonists have been defined for 9 of them.6 TLRs can function as homodimers or heterodimers, increasing the repertoire of specificities.7 TLR1, TLR2, and TLR6 are triggered by peptidoglycan and other microbial products,8,9 TLR3 by double-stranded RNA,10 TLR4 by lipopolysaccharide (LPS),11 TLR5 by flagellin,12 TLR7 and TLR8 by imidazoquinolines,6,13 and TLR9 by unmethylated CpG DNA.14, 15, 16, 17, 18, 19, 20, 21
TLRs are differentially expressed in dendritic cell (DC) subsets.22, 23, 24 Monocytes and myeloid DCs express TLR2 and TLR4 and respond to peptidoglycan and LPS, while plasmacytoid DCs express a reciprocal pattern—namely, TLR7 and TLR9 and respond to CpG. The induction of DC maturation by TLRs represents the functional link between innate and adaptive response.1,25 TLR expression can be regulated; for instance, interferon- (IFN-) up-regulates TLR4 expression in human phagocytes, enhancing their capacity to respond to LPS.26
Mouse B cells proliferate and differentiate in response to LPS or CpG,14,27 indicating that they express functional TLR4 and TLR9. Human B cells also respond to CpG,19 but recent data indicate that memory B cells are more responsive than naive B cells, raising the possibility that TLR expression may be differentially regulated in human naive and memory B cells.28 We report here that in human naive B cells TLRs are expressed at low to undetectable levels but their expression is rapidly up-regulated by B-cell-receptor (BCR) triggering. In contrast, memory B cells express several TLRs at constitutively high levels. The differential expression correlates with responsiveness to CpG DNA, an agonist of TLR9, and points to a relevant difference between human and mouse B cells. Thus, in humans TLRs are downstream of BCR and play a role in the late phase of acquired immunity.
|
Materials and methods
|
|---|
Cell isolation and culture
B lymphocytes were isolated from peripheral blood mononuclear cells (PBMCs) using CD19 microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and further purified by cell sorting using a FACSVantage (Becton Dickinson, San Jose, CA). Cells were stained with directly labeled antibodies to CD27 (Pharmingen, San Diego, CA) (to identify memory B cells) and appropriate combinations of monoclonal or polyclonal antibodies to CD14, CD3, CD16 (Beckman Coulter, Marseille, France), immunoglobulin (Ig) M, IgD, IgG, or IgA (Jackson ImmunoResearch, West Grove, PA) to obtain pure B subpopulations. Cells were labeled with 5- and 6-carboxyfluorescein diacetate succinimidyl ester (CFSE) and cultured at 3 x 104 cells per well in 96 flat-bottom microplates in complete RPMI 1640 supplemented with 10% fetal calf serum (FCS, HyClone Laboratories, Logan, UT). CpG oligodeoxynucleotide 2006 (5'-TCGTCGTTTTGTCGTTTTGTCGTT-3') complete phosphorothioate (Microsynth, Balgach, Switzerland) was used at the optimal concentration of 2.5 µg/mL. Titration experiments showed comparable results over a range of concentrations (1-10 µg/mL). Human recombinant interleukin-2 (IL-2) (R&D Systems, Minneapolis, MN) and IL-10 (Pharmingen) were used at 10 ng/mL. F(ab')2 fragments of goat antihuman Ig (Jackson ImmunoResearch) were used at 2 µg/mL.
Cell proliferation and Ig production
Purified B-cell populations were labeled with CFSE29 and cultured with appropriate stimuli. Cell proliferation was measured on day 5. Dead cells were gated out by the use of propidium iodide (Sigma, St Louis, MO). Ig-secreting cells (ISCs) were detected by isotype-specific enzyme linked immunospot assay (ELISPOT) on day 6 of culture. Briefly, 96-well plates (Millipore, MAIPS4510) were coated with 1 µg/mL purified goat antihuman IgG, IgA, or IgM (Southern Biotechnology, Birmingham, AL). After washing and blocking with phosphate buffered saline (PBS) 1% bovine serum albumin (BSA), appropriate numbers of cells were added to the plates and incubated overnight at 37°C. Plates were washed with PBS and PBS/0.05% Tween and incubated with isotype-specific secondary antibodies, followed by streptavidin–horseradish peroxidase (streptavidin-HRP) (Sigma). The assay was developed with 3-amino-9-ethylcarbazole (AEC) (Sigma) as a chromogenic substrate.
PCR and Taqman analysis
Total RNA was isolated from naive and memory B-cell subsets using TRIZOL Reagent (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions. RNA samples were treated with DNase I to remove contaminating genomic DNA. First-strand cDNA was synthesized at 37°C for 1 hour in 20 µL reaction mixture using random primers and Moloney murine leukemia virus reverse transcriptase (M-MLV RT) (Invitrogen). Serially diluted cDNA samples were amplified using a Taq DNA polymerase (Invitrogen). The primers for TLR1-9 were previously described.22 Other primers used for polymerase chain reaction (PCR) were as follows: TLR10: 5'-ATGAGACTCATCAGAAACATTTAC-3' and 5'-GCGGATCCGCTACCTTCTTCATAATG-3'; RP105: 5'-CTGCTTCTTTTGGGTGGTGCT-3' and 5'-CTCGAGATTGGATATTCCCGT-3'; MD-1: 5'-CTCTACCAGAGTTGCGATCCATTACAA-3' and 5'-TCAGGAGCACATGATAGTAGCATTG-3'; MD-2: 5'-GGGTCTGCAACTCATCCGAT-3' and 5'-GGTGTAGGATGACAAACTCCAAGC-3'; MyD88: 5'-TGGTGGTGGTTGTCTCTGATG-3' and 5'-CCAGAACCAAGATTTGGTGCA-3'; Btk: 5'-ATCTGATTTCGGCCTGTCCAG-3' and 5'-CATCTGCTTTCTCATGCCAACA-3'; Pax-5: 5'-AATCCCACCATGTTTGCCTG-3' and 5'-CGGAGACTCCTGAATACCTTC-3'. PCR products were resolved on a 2.0% agarose gel and visualized by ethidium bromide staining.
Quantification of TLR2, TLR4, TLR7, and TLR9 mRNAs was done by real-time quantitative PCR using an ABI PRISM 7700 sequence detector (Applied Biosystems, Foster City, CA) and Taqman reagents according to manufacturer instructions. The sequences of probes and primers used were as follows for TLR7: probe: 5'-AGATACCGCAGGGCCTCCCGC-3'; primer: 5'-TTACCTGGATGGAAACCAGCTACT-3' and 5'-TCAAGGCTGAGAAGCTGTAAGCTA-3'. The sequences of probes and primers used for TLR2, TLR4, and TLR9 were described previously.22 Amplification of  -actin was done for each experimental sample as endogenous control to account for differences in the amount and quality of total RNA added to each reaction.
|
Results
|
|---|
Differential expression of TLRs in naive and memory B-cell subsets
Human memory B lymphocytes can be identified according to the expression of CD27.30 Total B lymphocytes were isolated from PBMCs using CD19 microbeads and stained with antibodies to CD27 and Ig isotypes to discriminate between naive and memory B-cell subsets.30,31 Naive (CD27-), IgM memory (CD27+, IgG-, IgA-), and switch memory B cells (CD27+, IgM-, IgD-) were isolated by cell sorting. The expression of TLR1 through TLR10 was assessed by semiquantitative PCR analysis using as starting material graded numbers of B cells (Figure 1). While the expression of -actin, Pax-5, Btk, and MyD88 was comparable in naive and memory B cells, the expression of TLRs varied remarkably. TLR1 and TLR2 were expressed at low levels in both naive and memory B cells. In contrast, TLR6, TLR7, TLR9, and TLR10 were expressed at low to undetectable levels in naive B cells and at high levels in memory B cells. The TLR-like gene RP-105 32 and the TLR4-associated receptors MD-1 and MD-2 were also expressed at higher levels in memory B cells compared with naive B cells. TLR4 and TLR8 were not detectable within the sensitivity of the assay. The expression of TLR2, TLR4, TLR7, and TLR9 was confirmed by real-time PCR (Figure 1B). TLR2 and TLR4 were expressed at very low levels and did not show consistent differences between naive and memory cells, while TLR7 and especially TLR9 levels were much higher in memory than naive B cells. Taken together, the above data indicate that in human B cells the expression of several TLRs is developmentally regulated.
BCR triggering rapidly up-regulates TLR9 expression in naive B cells
We considered the possibility that BCR triggering might upregulate TLR expression in naive B cells, thus selectively sensitizing the antigen-specific B cells to respond to polyclonal activators. We focused our analysis on TLR9 regulation, because this is a major TLR expressed by human B cells and because a potent agonist (CpG 2006) is available.18 Naive, IgM memory, and switch memory B cells were cultured in medium alone or in the presence of F(ab')2 fragments of goat antihuman Ig antibodies (anti-Ig) or CpG 2006. Cells were harvested at different time points, and mRNA levels were measured by real-time PCR (Figure 2A). Naive B cells triggered by anti-Ig rapidly up-regulated TLR9 mRNA (about 8-fold in 2 hours), while stimulation with CpG 2006 induced a lower and variable response and did not significantly synergize with anti-Ig. IgM memory and switch memory B cells showed higher basal levels of TLR9 mRNA and a proportionally much lower increase in response to the stimuli. TLR10 was also up-regulated in naive B cells by anti-Ig but with a slower kinetics compared with TLR9 (Figure 2B). These results indicate that in human naive B cells, TLR9 expression is regulated by BCR triggering.
BCR triggering is required for CpG-induced activation of naive B cells but is dispensable for activation of memory B cells
The up-regulation of TLR9 expression following BCR triggering suggests that these stimuli may synergize in the activation of naive B cells. We therefore stimulated naive and memory B-cell subsets with CpG, anti-Ig, and cytokines in various combinations and measured their proliferative response using the CFSE dilution method29 (Figure 3). Two observations were made. First, naive B cells proliferated only when stimulated by anti-Ig, CpG, IL-2, and IL-10, while the response of memory B cells was comparable in the presence or in the absence of anti-Ig. Second, IgM memory B cells, and to a lower extent switch memory B cells, were able to proliferate in response to CpG even in the absence of exogenous cytokines. This response was completely inhibited by IL-10. However, IL-10 was synergistic rather than inhibitory when added together with IL-2.
View larger version (20K):
[in this window]
[in a new window]
|
Figure 3.. Differential requirements for naive and memory B-cell proliferation. Naive and memory B-cell subsets were isolated as in Figure 1, labeled with CFSE, and cultured with CpG 2006, anti-Ig, and cytokines in different combinations. Cell proliferation was assessed on day 5. CFSE is on a 4-log scale. One representative experiment of 10.
|
|
Using an isotype-specific ELISPOT assay, we measured the differentiation of naive and memory B cells to ISCs (Figure 4). Consistent with the proliferation data, we observed a striking synergy between anti-Ig, CpG, and cytokines in the activation of naive B cell. In contrast, anti-Ig did not significantly affect the response of memory B cells. IgM memory B cells generated large numbers of ISCs, which were almost exclusively IgM, indicating that these cells do not switch, at least under these culture conditions. Switch memory B cells generated IgG and IgA ISCs in relatively constant proportions irrespective of the nature of the stimulus. The inhibitory effect of IL-10 was also observed for ISC generation.
|
Discussion
|
|---|
We have shown that TLR9 is expressed at very low level in human naive B cells; it is rapidly up-regulated by BCR triggering; and it is expressed at a high constitutive levels in memory B cells. Consistent with these observations, memory B cells are directly triggered by CpG to proliferate and differentiate to ISCs, while naive B cells require synergistic stimulation by anti-Ig and CpG.
In this study we focused primarily on TLR9, because it is expressed at high level in human B cells and its ligand is a powerful B-cell mitogen. However, human B cells express several TLRs that show distinct expression patterns in naive and memory cells. TLR6, TLR7, TLR9, and TLR10 are expressed at low levels in naive B and at high levels in memory B cells. Because TLR10 is expressed at high level in B cells, the identification of TLR10 ligands will offer the opportunity to selectively target B cells without affecting myeloid or plasmacytoid DCs. Other TLRs— namely, TLR1, TLR2, and TLR4—are expressed at comparable levels by naive and memory B cells, this level being particularly low for TLR2 and TLR4. Human B cells express very low levels of TLR4 and although they express MD-2 and RP105 they fail to respond to LPS (N.L.B., unpublished data, 2002).
Previous studies in the mouse system provided evidence for a synergism between BCR and TLRs. These studies suggested that antigens containing polyclonal activator, such as LPS or unmethylated DNA, may act as a physical bridge between BCR and TLRs, which are constitutively expressed on mouse naive B cells, the cross-linking of the 2 receptors leading to B-cell proliferation and differentiation.27,33 On the basis of our results we propose a revised model based on a temporal bridge between BCR and TLR9. First, antigen binds to BCR and triggers TLR9 expression. Second, antigen and the associated TLR9 ligand is internalized in the endosomal compartment, where it interacts with newly synthesized TLR9. This model is consistent with our data as well as with the intracellular expression of TLR9.34 The induction of gene expression ensures fidelity in primary response.
CpG DNA has been traditionally considered as an adjuvant for T- and B-cell responses.15 A recent study suggests that CpG DNA potentiates the B-cell adaptive immune response by enhancing terminal differentiation.35 We have shown here that naive and memory B-cell proliferation and differentiation can be induced in the complete absence of T cells. Our study suggests that direct coupling of antigen to CpG may be sufficient to create a strong immunogen capable of eliciting highly specific T-independent antibody responses.
The constitutive expression of TLRs in memory cells provides a mechanistic explanation to our recent findings that CpG can selectively trigger memory cells.28 It should be noted that in response to CpG naive B cells do not proliferate but up-regulate CD69 and, to a lower extent, CD86 within 4 hours after stimulation.28 This indicates that in naive B cells some signal is transmitted in response to CpG. The failure of CpG to induce proliferation of naive B cells may be due to the fact that TLR9 is either expressed at too low levels or is inefficiently coupled to signal transduction pathways. In addition, our results reveal that IL-10 can potently inhibit CpG-induced B-cell proliferation, an effect that is contingent on the presence of IL-2. Indeed, when added alone IL-10 completely inhibited the CpG-induced B-cell proliferation, while in the presence of IL-2 it enhanced B-cell proliferation. These findings suggest a new role for IL-10 as a "fine-tuner" of B-cell activation induced by microbial products. In this respect, it is tempting to hypothesize that, in the absence of IL-10 polyclonal activation of IgM memory B cells by chronic infection may induce the continuous proliferation leading to the development of mucosa-associated lymphatic tissue (MALT) lymphomas.36
In conclusion, our results suggest a novel role for TLRs in the immune response. In dendritic cells, TLRs function as primary triggers for dendritic cell maturation and cytokine production and in this way bridge innate to adaptive immunity. In contrast, in human B cells, TLRs function downstream of BCR and play distinct functions in primary responses and immunologic memory. Selective TLR9 up-regulation in BCR-triggered B cells makes so that in a T-independent response only the naive B cells that have captured microbial antigens will be activated. In contrast, the constitutive expression of TLRs in memory B cells provides a mechanism to continuously generate antibody of all memory specificities, thus sustaining serologic memory.
|
Acknowledgements
|
|---|
We thank Federica Sallusto for critical reading of the manuscript.
|
Footnotes
|
|---|
Submitted November 26, 2002;
accepted January 23, 2003.
Prepublished online as Blood First Edition Paper, January 30, 2003; DOI 10.1182/blood-2002-11-3569.
Supported by the Swiss National Science Foundation (grant 31-63885). A.L. is supported by the Helmut Horten Foundation.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Antonio Lanzavecchia, Institute for Research in Biomedicine, Via Vela 6, 6500 Bellinzona, Switzerland; e-mail: lanzavecchia{at}irb.unisi.ch.
|
References
|
|---|
- Medzhitov R, Janeway C Jr. Innate immunity. N Engl J Med. 2000;343: 338-344.[Free Full Text]
- Muzio M, Polentarutti N, Bosisio D, Prahladan MK, Mantovani A. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J Leukoc Biol. 2000;67: 450-456.[Abstract]
- Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001;2: 675-680.[CrossRef][Medline]
[Order article via Infotrieve]
- Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406: 782-787.[CrossRef][Medline]
[Order article via Infotrieve]
- Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A. The human toll signaling pathway: divergence of nuclear factor B and JNK/SAPK activation upstream of tumor necrosis factor receptorassociated factor 6 (TRAF6). J Exp Med. 1998;187: 2097-2101.[Abstract/Free Full Text]
- Akira S. Mammalian Toll-like receptors. Curr Opin Immunol. 2003;15: 5-11.[CrossRef][Medline]
[Order article via Infotrieve]
- Ozinsky A, Underhill DM, Fontenot JD, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci U S A. 2000;97: 13766-13771.[Abstract/Free Full Text]
- Campos MA, Almeida IC, Takeuchi O, et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol. 2001;167: 416-423.[Abstract/Free Full Text]
- Underhill DM, Ozinsky A, Hajjar AM, et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature. 1999;401: 811-815.[CrossRef][Medline]
[Order article via Infotrieve]
- Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-B by Toll-like receptor 3. Nature. 2001;413: 732-738.[CrossRef][Medline]
[Order article via Infotrieve]
- Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282: 2085-2088.[Abstract/Free Full Text]
- Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;410: 1099-1103.[CrossRef][Medline]
[Order article via Infotrieve]
- Hemmi H, Kaisho T, Takeuchi O, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002;3: 196-200.[CrossRef][Medline]
[Order article via Infotrieve]
- Krieg AM, Yi AK, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 1995;374: 546-549.[CrossRef][Medline]
[Order article via Infotrieve]
- Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002;20: 709-760.[CrossRef][Medline]
[Order article via Infotrieve]
- Hacker H, Mischak H, Miethke T, et al. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 1998;17: 6230-6240.[CrossRef][Medline]
[Order article via Infotrieve]
- Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408: 740-745.[CrossRef][Medline]
[Order article via Infotrieve]
- Hartmann G, Weeratna RD, Ballas ZK, et al. De-lineation of a CpG phosphorothioate oligode-oxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol. 2000;164: 1617-1624.[Abstract/Free Full Text]
- Hartmann G, Krieg AM. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol. 2000;164: 944-953.[Abstract/Free Full Text]
- Bauer S, Kirschning CJ, Hacker H, et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci U S A. 2001;98: 9237-9242.[Abstract/Free Full Text]
- Takeshita F, Leifer CA, Gursel I, et al. Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol. 2001;167: 3555-3558.[Abstract/Free Full Text]
- Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur J Immunol. 2001;31: 3388-3393.[CrossRef][Medline]
[Order article via Infotrieve]
- Kadowaki N, Ho S, Antonenko S, et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 2001;194: 863-869.[Abstract/Free Full Text]
- Krug A, Towarowski A, Britsch S, et al. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol. 2001;31: 3026-3037.[CrossRef][Medline]
[Order article via Infotrieve]
- Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 2001;106: 259-262.[CrossRef][Medline]
[Order article via Infotrieve]
- Bosisio D, Polentarutti N, Sironi M, et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood. 2002;99: 3427-3431.[Abstract/Free Full Text]
- Coutinho A, Gronowicz E, Bullock WW, Moller G. Mechanism of thymus-independent immunocyte triggering: mitogenic activation of B cells results in specific immune responses. J Exp Med. 1974;139: 74-92.[Abstract]
- Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2002;298: 2199-2202.[Abstract/Free Full Text]
- Lyons AB, Parish CR. Determination of lymphocyte division by flow cytometry. J Immunol Methods. 1994;171: 131-137.[CrossRef][Medline]
[Order article via Infotrieve]
- Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med. 1998;188: 1679-1689.[Abstract/Free Full Text]
- Klein U, Kuppers R, Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood. 1997;89: 1288-1298.[Abstract/Free Full Text]
- Chan VW, Mecklenbrauker I, Su I, et al. The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J Exp Med. 1998;188: 93-101.[Abstract/Free Full Text]
- Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002;416: 603-607.[CrossRef][Medline]
[Order article via Infotrieve]
- Ahmad-Nejad P, Hacker H, Rutz M, Bauer S, Vabulas RM, Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol. 2002;32: 1958-1968.[CrossRef][Medline]
[Order article via Infotrieve]
- Jung J, Yi AK, Zhang X, Choe J, Li L, Choi YS. Distinct response of human B cell subpopulations in recognition of an innate immune signal, CpG DNA. J Immunol. 2002;169: 2368-2373.[Abstract/Free Full Text]
- Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341: 1520-1529.[Free Full Text]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
CpG: unraveling the key to B-cell function
- Gunther Hartmann
Blood 2003 101: 4230-4231.
[Full Text]
[PDF]
This article has been cited by other articles:
|
|
|
|
 
S Zorro, M Arias, F Riano, S Paris, L. Ramirez, O Uribe, L. Garcia, and G Vasquez
Response to ODN-CpG by B Cells from patients with systemic lupus erythematosus correlates with disease activity
Lupus,
July 1, 2009;
18(8):
718 - 726.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Fukui, S.-i. Saitoh, F. Matsumoto, H. Kozuka-Hata, M. Oyama, K. Tabeta, B. Beutler, and K. Miyake
Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing
J. Exp. Med.,
June 8, 2009;
206(6):
1339 - 1350.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. K. Pierce and L. H. Miller
World Malaria Day 2009: What Malaria Knows about the Immune System That Immunologists Still Do Not
J. Immunol.,
May 1, 2009;
182(9):
5171 - 5177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Morales-Aza, S. J. Glennie, T. P. Garcez, V. Davenport, S. L. Johnston, N. A. Williams, and R. S. Heyderman
Impaired maintenance of naturally acquired T-cell memory to the meningococcus in patients with B-cell immunodeficiency
Blood,
April 30, 2009;
113(18):
4206 - 4212.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Jendholm, M. Morgelin, M. L. A. Perez Vidakovics, M. Carlsson, H. Leffler, L.-O. Cardell, and K. Riesbeck
Superantigen- and TLR-Dependent Activation of Tonsillar B Cells after Receptor-Mediated Endocytosis
J. Immunol.,
April 15, 2009;
182(8):
4713 - 4720.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. D. Crompton, M. Mircetic, G. Weiss, A. Baughman, C.-Y. Huang, D. J. Topham, J. J. Treanor, I. Sanz, F. E.-H. Lee, A. P. Durbin, et al.
The TLR9 Ligand CpG Promotes the Acquisition of Plasmodium falciparum-Specific Memory B Cells in Malaria-Naive Individuals
J. Immunol.,
March 1, 2009;
182(5):
3318 - 3326.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Douagi, C. Gujer, C. Sundling, W. C. Adams, A. Smed-Sorensen, R. A. Seder, G. B. Karlsson Hedestam, and K. Lore
Human B Cell Responses to TLR Ligands Are Differentially Modulated by Myeloid and Plasmacytoid Dendritic Cells
J. Immunol.,
February 15, 2009;
182(4):
1991 - 2001.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. L. Good, D. T. Avery, and S. G. Tangye
Resting Human Memory B Cells Are Intrinsically Programmed for Enhanced Survival and Responsiveness to Diverse Stimuli Compared to Naive B Cells
J. Immunol.,
January 15, 2009;
182(2):
890 - 901.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Sandanger, L. Ryan, J. Bohnhorst, A.-C. Iversen, H. Husebye, O. Halaas, L. Landro, P. Aukrust, S. S. Froland, G. Elson, et al.
IL-10 Enhances MD-2 and CD14 Expression in Monocytes and the Proteins Are Increased and Correlated in HIV-Infected Patients
J. Immunol.,
January 1, 2009;
182(1):
588 - 595.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Malaspina, S. Moir, A. C. DiPoto, J. Ho, W. Wang, G. Roby, M. A. O'Shea, and A. S. Fauci
CpG Oligonucleotides Enhance Proliferative and Effector Responses of B Cells in HIV-Infected Individuals
J. Immunol.,
July 15, 2008;
181(2):
1199 - 1206.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Xu, P. A. Santini, A. J. Matthews, A. Chiu, A. Plebani, B. He, K. Chen, and A. Cerutti
Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF
J. Immunol.,
July 1, 2008;
181(1):
276 - 287.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Rosen, W. Cao, D. T. Avery, S. G. Tangye, Y.-J. Liu, J. P. Houchins, and L. L. Lanier
Functional Consequences of Interactions between Human NKR-P1A and Its Ligand LLT1 Expressed on Activated Dendritic Cells and B Cells
J. Immunol.,
May 15, 2008;
180(10):
6508 - 6517.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ahuja, S. M. Anderson, A. Khalil, and M. J. Shlomchik
Maintenance of the plasma cell pool is independent of memory B cells
PNAS,
March 25, 2008;
105(12):
4802 - 4807.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Forsbach, J.-G. Nemorin, C. Montino, C. Muller, U. Samulowitz, A. P. Vicari, M. Jurk, G. K. Mutwiri, A. M. Krieg, G. B. Lipford, et al.
Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses
J. Immunol.,
March 15, 2008;
180(6):
3729 - 3738.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. V. Rubtsov, C. L. Swanson, S. Troy, P. Strauch, R. Pelanda, and R. M. Torres
TLR Agonists Promote Marginal Zone B Cell Activation and Facilitate T-Dependent IgM Responses
J. Immunol.,
March 15, 2008;
180(6):
3882 - 3888.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Capolunghi, S. Cascioli, E. Giorda, M. M. Rosado, A. Plebani, C. Auriti, G. Seganti, R. Zuntini, S. Ferrari, M. Cagliuso, et al.
CpG Drives Human Transitional B Cells to Terminal Differentiation and Production of Natural Antibodies
J. Immunol.,
January 15, 2008;
180(2):
800 - 808.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N.-H. Chang, T. McKenzie, G. Bonventi, C. Landolt-Marticorena, P. R. Fortin, D. Gladman, M. Urowitz, and J. E. Wither
Expanded Population of Activated Antigen-Engaged Cells within the Naive B Cell Compartment of Patients with Systemic Lupus Erythematosus
J. Immunol.,
January 15, 2008;
180(2):
1276 - 1284.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Loiarro, F. Capolunghi, N. Fanto, G. Gallo, S. Campo, B. Arseni, R. Carsetti, P. Carminati, R. De Santis, V. Ruggiero, et al.
Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound
J. Leukoc. Biol.,
October 1, 2007;
82(4):
801 - 810.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Gary-Gouy, A. Sainz-Perez, J.-B. Marteau, A. Marfaing-Koka, J. Delic, H. Merle-Beral, P. Galanaud, and A. Dalloul
Natural Phosphorylation of CD5 in Chronic Lymphocytic Leukemia B Cells and Analysis of CD5-Regulated Genes in a B Cell Line Suggest a Role for CD5 in Malignant Phenotype
J. Immunol.,
October 1, 2007;
179(7):
4335 - 4344.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. J. Martin, J. M. Lee, D. Walls, and S. D. Hayward
Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus
J. Virol.,
September 15, 2007;
81(18):
9748 - 9758.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. C. W. Ploegaert, G. De Vries Reilingh, M. G. B. Nieuwland, A. Lammers, H. F. J. Savelkoul, and H. K. Parmentier
Intratracheally Administered Pathogen-Associated Molecular Patterns Affect Antibody Responses of Poultry
Poult. Sci.,
August 1, 2007;
86(8):
1667 - 1676.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Krieg
Antiinfective Applications of Toll-like Receptor 9 Agonists
Proceedings of the ATS,
July 1, 2007;
4(3):
289 - 294.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Genestier, M. Taillardet, P. Mondiere, H. Gheit, C. Bella, and T. Defrance
TLR Agonists Selectively Promote Terminal Plasma Cell Differentiation of B Cell Subsets Specialized in Thymus-Independent Responses
J. Immunol.,
June 15, 2007;
178(12):
7779 - 7786.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Star, K. Frankena, B. Kemp, M. G. B. Nieuwland, and H. K. Parmentier
Natural Humoral Immune Competence and Survival in Layers
Poult. Sci.,
June 1, 2007;
86(6):
1090 - 1099.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. B. Ewaschuk, J. L. Backer, T. A. Churchill, F. Obermeier, D. O. Krause, and K. L. Madsen
Surface Expression of Toll-Like Receptor 9 Is Upregulated on Intestinal Epithelial Cells in Response to Pathogenic Bacterial DNA
Infect. Immun.,
May 1, 2007;
75(5):
2572 - 2579.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ertesvag, H.-C. Aasheim, S. Naderi, and H. K. Blomhoff
Vitamin A potentiates CpG-mediated memory B-cell proliferation and differentiation: involvement of early activation of p38MAPK
Blood,
May 1, 2007;
109(9):
3865 - 3872.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Bekeredjian-Ding, S. Inamura, T. Giese, H. Moll, S. Endres, A. Sing, U. Zahringer, and G. Hartmann
Staphylococcus aureus Protein A Triggers T Cell-Independent B Cell Proliferation by Sensitizing B Cells for TLR2 Ligands
J. Immunol.,
March 1, 2007;
178(5):
2803 - 2812.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Huggins, T. Pellegrin, R. E. Felgar, C. Wei, M. Brown, B. Zheng, E. C. B. Milner, S. H. Bernstein, I. Sanz, and M. S. Zand
CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells
Blood,
February 15, 2007;
109(4):
1611 - 1619.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wang, Y. Shao, T. A. Bennett, R. A. Shankar, P. D. Wightman, and L. G. Reddy
The Functional Effects of Physical Interactions among Toll-like Receptors 7, 8, and 9
J. Biol. Chem.,
December 8, 2006;
281(49):
37427 - 37434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. K. Parmentier, L. Star, S. C. Sodoyer, M. G. B. Nieuwland, G. De Vries Reilingh, A. Lammers, and B. Kemp
Age- and Breed-Dependent Adapted Immune Responsiveness of Poultry to Intratracheal-Administered, Pathogen-Associated Molecular Patterns
Poult. Sci.,
December 1, 2006;
85(12):
2156 - 2168.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Deane and S. Bolland
Nucleic Acid-Sensing TLRs as Modifiers of Autoimmunity
J. Immunol.,
November 15, 2006;
177(10):
6573 - 6578.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Lewkowicz, N. Lewkowicz, A. Sasiak, and H. Tchorzewski
Lipopolysaccharide-Activated CD4+CD25+ T Regulatory Cells Inhibit Neutrophil Function and Promote Their Apoptosis and Death
J. Immunol.,
November 15, 2006;
177(10):
7155 - 7163.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. L. Good, V. L. Bryant, and S. G. Tangye
Kinetics of Human B Cell Behavior and Amplification of Proliferative Responses following Stimulation with IL-21
J. Immunol.,
October 15, 2006;
177(8):
5236 - 5247.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. E. Gunn and J. W. Brewer
Evidence That Marginal Zone B Cells Possess an Enhanced Secretory Apparatus and Exhibit Superior Secretory Activity
J. Immunol.,
September 15, 2006;
177(6):
3791 - 3798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Wang, M. W. Nicholas, K. L. Conway, P. Sen, R. Diz, R. M. Tisch, and S. H. Clarke
EBV Latent Membrane Protein 2A Induces Autoreactive B Cell Activation and TLR Hypersensitivity.
J. Immunol.,
September 1, 2006;
177(5):
2793 - 2802.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. He, X. Qiao, P. J. Klasse, A. Chiu, A. Chadburn, D. M. Knowles, J. P. Moore, and A. Cerutti
HIV-1 Envelope Triggers Polyclonal Ig Class Switch Recombination through a CD40-Independent Mechanism Involving BAFF and C-Type Lectin Receptors
J. Immunol.,
April 1, 2006;
176(7):
3931 - 3941.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Ito, H. Kanzler, O. Duramad, W. Cao, and Y.-J. Liu
Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells
Blood,
March 15, 2006;
107(6):
2423 - 2431.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Schlaepfer, A. Audige, H. Joller, and R. F. Speck
TLR7/8 Triggering Exerts Opposing Effects in Acute versus Latent HIV Infection.
J. Immunol.,
March 1, 2006;
176(5):
2888 - 2895.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Tsuiji, S. Yurasov, K. Velinzon, S. Thomas, M. C. Nussenzweig, and H. Wardemann
A checkpoint for autoreactivity in human IgM+ memory B cell development
J. Exp. Med.,
February 21, 2006;
203(2):
393 - 400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Cunningham-Rundles, L. Radigan, A. K. Knight, L. Zhang, L. Bauer, and A. Nakazawa
TLR9 Activation Is Defective in Common Variable Immune Deficiency
J. Immunol.,
February 1, 2006;
176(3):
1978 - 1987.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Corcione, F. Benvenuto, E. Ferretti, D. Giunti, V. Cappiello, F. Cazzanti, M. Risso, F. Gualandi, G. L. Mancardi, V. Pistoia, et al.
Human mesenchymal stem cells modulate B-cell functions
Blood,
January 1, 2006;
107(1):
367 - 372.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. A. Souza, B. D. Stollar, J. L. Sullivan, K. Luzuriaga, and D. A. Thorley-Lawson
Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells
PNAS,
December 13, 2005;
102(50):
18093 - 18098.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Guo, S. Garg, K. M. Hill, L. Jayashankar, M. R. Mooney, M. Hoelscher, J. M. Katz, J. M. Boss, and S. Sambhara
A Distal Regulatory Region Is Required for Constitutive and IFN-{beta}-Induced Expression of Murine TLR9 Gene
J. Immunol.,
December 1, 2005;
175(11):
7407 - 7418.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Butler, D. H. Francis, J. Freeling, P. Weber, and A. M. Krieg
Antibody Repertoire Development in Fetal and Neonatal Piglets. IX. Three Pathogen-Associated Molecular Patterns Act Synergistically to Allow Germfree Piglets to Respond to Type 2 Thymus-Independent and Thymus-Dependent Antigens
J. Immunol.,
November 15, 2005;
175(10):
6772 - 6785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. P. Ho, P. Fontoura, M. Platten, R. A. Sobel, J. J. DeVoss, L. Y. Lee, B. A. Kidd, B. H. Tomooka, J. Capers, A. Agrawal, et al.
A Suppressive Oligodeoxynucleotide Enhances the Efficacy of Myelin Cocktail/IL-4-Tolerizing DNA Vaccination and Treats Autoimmune Disease
J. Immunol.,
November 1, 2005;
175(9):
6226 - 6234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Christensen, M. Kashgarian, L. Alexopoulou, R. A. Flavell, S. Akira, and M. J. Shlomchik
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
J. Exp. Med.,
July 18, 2005;
202(2):
321 - 331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Hoogendoorn, J. Olde Wolbers, W. M. Smit, M. R. Schaafsma, I. Jedema, R. M.Y. Barge, R. Willemze, and J.H. F. Falkenburg
Primary Allogeneic T-Cell Responses against Mantle Cell Lymphoma Antigen-Presenting Cells for Adoptive Immunotherapy after Stem Cell Transplantation
Clin. Cancer Res.,
July 15, 2005;
11(14):
5310 - 5318.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Wang, R. Alvarez, G. Roderiquez, E. Guan, Q. Caldwell, J. Wang, M. Phelan, and M. A. Norcross
CpG-Independent Synergistic Induction of {beta}-Chemokines and a Dendritic Cell Phenotype by Orthophosphorothioate Oligodeoxynucleotides and Granulocyte-Macrophage Colony-Stimulating Factor in Elutriated Human Primary Monocytes
J. Immunol.,
May 15, 2005;
174(10):
6113 - 6121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Muehlinghaus, L. Cigliano, S. Huehn, A. Peddinghaus, H. Leyendeckers, A. E. Hauser, F. Hiepe, A. Radbruch, S. Arce, and R. A. Manz
Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells
Blood,
May 15, 2005;
105(10):
3965 - 3971.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Bende, W. M. Aarts, R. G. Riedl, D. de Jong, S. T. Pals, and C. J.M. van Noesel
Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
J. Exp. Med.,
April 18, 2005;
201(8):
1229 - 1241.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Jahrsdorfer, L. Muhlenhoff, S. E. Blackwell, M. Wagner, H. Poeck, E. Hartmann, R. Jox, T. Giese, B. Emmerich, S. Endres, et al.
B-Cell Lymphomas Differ in their Responsiveness to CpG Oligodeoxynucleotides
Clin. Cancer Res.,
February 15, 2005;
11(4):
1490 - 1499.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Odendahl, H. Mei, B. F. Hoyer, A. M. Jacobi, A. Hansen, G. Muehlinghaus, C. Berek, F. Hiepe, R. Manz, A. Radbruch, et al.
Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response
Blood,
February 15, 2005;
105(4):
1614 - 1621.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Vanlandschoot, F. Van Houtte, P. Ulrichts, J. Tavernier, and G. Leroux-Roels
Immunostimulatory potential of hepatitis B nucleocapsid preparations: lipopolysaccharide contamination should not be overlooked
J. Gen. Virol.,
February 1, 2005;
86(2):
323 - 331.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. B. Gorden, K. S. Gorski, S. J. Gibson, R. M. Kedl, W. C. Kieper, X. Qiu, M. A. Tomai, S. S. Alkan, and J. P. Vasilakos
Synthetic TLR Agonists Reveal Functional Differences between Human TLR7 and TLR8
J. Immunol.,
February 1, 2005;
174(3):
1259 - 1268.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. U. Saikh, T. L. Kissner, A. Sultana, G. Ruthel, and R. G. Ulrich
Human Monocytes Infected with Yersinia pestis Express Cell Surface TLR9 and Differentiate into Dendritic Cells
J. Immunol.,
December 15, 2004;
173(12):
7426 - 7434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Eaton-Bassiri, S. B. Dillon, M. Cunningham, M. A. Rycyzyn, J. Mills, R. T. Sarisky, and M. L. Mbow
Toll-Like Receptor 9 Can Be Expressed at the Cell Surface of Distinct Populations of Tonsils and Human Peripheral Blood Mononuclear Cells
Infect. Immun.,
December 1, 2004;
72(12):
7202 - 7211.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F Y Liew, M Komai-Koma, and D Xu
A toll for T cell costimulation
Ann Rheum Dis,
November 1, 2004;
63(suppl_2):
ii76 - ii78.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Lazarus, B. A. Raby, C. Lange, E. K. Silverman, D. J. Kwiatkowski, D. Vercelli, W. J. Klimecki, F. D. Martinez, and S. T. Weiss
TOLL-like Receptor 10 Genetic Variation Is Associated with Asthma in Two Independent Samples
Am. J. Respir. Crit. Care Med.,
September 15, 2004;
170(6):
594 - 600.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Lieby, V. Poindron, S. Roussi, C. Klein, A.-M. Knapp, J.-C. Garaud, M. Cerutti, T. Martin, and J.-L. Pasquali
Pathogenic antiphospholipid antibody: an antigen-selected needle in a haystack
Blood,
September 15, 2004;
104(6):
1711 - 1715.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Takeshita, K. Suzuki, S. Sasaki, N. Ishii, D. M. Klinman, and K. J. Ishii
Transcriptional Regulation of the Human TLR9 Gene
J. Immunol.,
August 15, 2004;
173(4):
2552 - 2561.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Hausl, R. U. Ahmad, H. P. Schwarz, E. M. Muchitsch, P. L. Turecek, F. Dorner, and B. M. Reipert
Preventing restimulation of memory B cells in hemophilia A: a potential new strategy for the treatment of antibody-dependent immune disorders
Blood,
July 1, 2004;
104(1):
115 - 122.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Poeck, M. Wagner, J. Battiany, S. Rothenfusser, D. Wellisch, V. Hornung, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann
Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help
Blood,
April 15, 2004;
103(8):
3058 - 3064.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H.-J. Anders, B. Banas, and D. Schlondorff
Signaling Danger: Toll-Like Receptors and their Potential Roles in Kidney Disease
J. Am. Soc. Nephrol.,
April 1, 2004;
15(4):
854 - 867.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Komai-Koma, L. Jones, G. S. Ogg, D. Xu, and F. Y. Liew
TLR2 is expressed on activated T cells as a costimulatory receptor
PNAS,
March 2, 2004;
101(9):
3029 - 3034.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Hebeis, K. Klenovsek, P. Rohwer, U. Ritter, A. Schneider, M. Mach, and T. H. Winkler
Activation of Virus-specific Memory B Cells in the Absence of T Cell Help
J. Exp. Med.,
February 17, 2004;
199(4):
593 - 602.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Marshall, E. M. Hessel, J. Gregorio, C. Abbate, P. Yee, M. Chu, G. V. Nest, R. L. Coffman, and K. L. Fearon
Novel chimeric immunomodulatory compounds containing short CpG oligodeoxyribonucleotides have differential activities in human cells
Nucleic Acids Res.,
September 1, 2003;
31(17):
5122 - 5133.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
Top
Abstract
Introduction
), TLR4 (
), TLR7 (
), and TLR9 (
) by real-time PCR in naive and memory B-cell subsets. The data are normalized to the expression of 
indicates medium; 
, CpG; 
, CpG + anti-Ig. (B) Kinetics of TLR9 and TLR10 up-regulation in naive B cells determined by semiquantitative PCR. One representative experiment of 4.
, IgA.